Search by Drug Name or NDC
NDC 73153-0900-01 BREYANZI Details
BREYANZI
BREYANZI is a KIT in the CELLULAR THERAPY category. It is labeled and distributed by Juno Therapeutics, Inc.. The primary component is .
MedlinePlus Drug Summary
Lisocabtagene maraleucel is used to treat certain types of large B-cell lymphoma (a type of cancer that begins in the white blood cells) in adults whose cancer has returned or is unresponsive to other treatments. Lisocabtagene maraleucel is in a class of medications called autologous cellular immunotherapy, a type of medication prepared using cells from the patient's own blood. It works by causing the body's immune system (a group of cells, tissues, and organs that protects the body from attack by bacteria, viruses, cancer cells, and other substances that cause disease) to fight the cancer cells.
Related Packages: 73153-0900-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lisocabtagene Maraleucel Injection
Product Information
NDC | 73153-0900 |
---|---|
Product ID | 73153-900_1107bed2-4fa1-4953-b193-7d882c61f897 |
Associated GPIs | 21651050401820 |
GCN Sequence Number | 081910 |
GCN Sequence Number Description | lisocabtagene maraleucel VIAL 70X 10EXP6 INTRAVEN |
HIC3 | V35 |
HIC3 Description | ANTINEOPLASTIC - CAR-T CELL IMMUNOTHERAPY |
GCN | 49174 |
HICL Sequence Number | 047106 |
HICL Sequence Number Description | LISOCABTAGENE MARALEUCEL |
Brand/Generic | Brand |
Proprietary Name | BREYANZI |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Lisocabtagene maraleucel |
Product Type | CELLULAR THERAPY |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Juno Therapeutics, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA125714 |
Listing Certified Through | 2024-12-31 |
Package
NDC 73153-0900-01 (73153090001)
NDC Package Code | 73153-900-01 |
---|---|
Billing NDC | 73153090001 |
Package | 1 KIT in 1 CARTON (73153-900-01) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08) |
Marketing Start Date | 2021-02-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |